Skip to content

ProLung, Inc.: 10-Q filed 2013-12-09

What ProLung, Inc. reported in its quarterly report filed 2013-12-09 (fiscal Q3 2013): 24 published measures, 74 facts as tagged in accession 0001078782-13-002402.

This filing

Form
10-Q (quarterly report)
Filed
2013-12-09
Fiscal period
fiscal Q3 2013
Accession
0001078782-13-002402 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All ProLung, Inc. filings.

Reported measures

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2013-09-302,400,870USD
At 2012-12-312,384,466USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2013-09-30-2,341,684USD
At 2012-12-31-2,368,262USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2013-03-312,876USD
At 2012-03-310USD
At 2004-11-220USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2013-07-01 to 2013-09-30-393,289USD92
2013-04-01 to 2013-09-30-768,788USD183
2004-11-23 to 2013-09-30-8,122,059USD3234
2012-07-01 to 2012-09-30-625,732USD92
2012-04-01 to 2012-09-30-1,179,410USD183

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2013-04-01 to 2013-09-30-546,896USD183
2004-11-23 to 2013-09-30-5,017,792USD3234
2012-04-01 to 2012-09-30-804,224USD183

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2013-04-01 to 2013-09-30597,000USD183
2004-11-23 to 2013-09-305,086,058USD3234
2012-04-01 to 2012-09-30833,401USD183

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

PeriodValueUnitDays
2013-04-01 to 2013-09-30-1,703USD183
2004-11-23 to 2013-09-30-16,989USD3234
2012-04-01 to 2012-09-30-14,721USD183

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

PeriodValueUnitDays
2013-04-01 to 2013-09-30196,813USD183
2004-11-23 to 2013-09-301,993,335USD3234
2012-04-01 to 2012-09-30248,912USD183

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2013-07-01 to 2013-09-30-342,307USD92
2013-04-01 to 2013-09-30-617,754USD183
2004-11-23 to 2013-09-30-7,377,790USD3234
2012-07-01 to 2012-09-30-565,228USD92
2012-04-01 to 2012-09-30-1,019,540USD183

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2013-09-3051,277USD
At 2012-12-312,876USD

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

PeriodValueUnitDays
2013-07-01 to 2013-09-30-50,982USD92
2013-04-01 to 2013-09-30-151,034USD183
2004-11-23 to 2013-09-30-1,010,949USD3234
2012-07-01 to 2012-09-30-60,504USD92
2012-04-01 to 2012-09-30-159,870USD183

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2013-09-301,034,512USD
At 2012-12-31873,108USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

PeriodValueUnitDays
At 2013-09-3062,926USD
At 2012-12-31190,110USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2013-07-01 to 2013-09-30342,307USD92
2013-04-01 to 2013-09-30727,754USD183
2004-11-23 to 2013-09-307,587,790USD3234
2012-07-01 to 2012-09-30565,228USD92
2012-04-01 to 2012-09-301,019,540USD183

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

PeriodValueUnitDays
2013-07-01 to 2013-09-3017,850USD92
2013-04-01 to 2013-09-3070,880USD183
2004-11-23 to 2013-09-305,257,672USD3234
2012-07-01 to 2012-09-30244,672USD92
2012-04-01 to 2012-09-30598,612USD183

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2013-09-3014,309,229shares
At 2012-12-3111,452,675shares

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

PeriodValueUnitDays
At 2013-09-305,766,066USD
At 2012-12-314,973,557USD

Gross property, plant and equipment

Cost of property, plant and equipment before accumulated depreciation. Historical cost does not indicate current value or replacement cost.

PeriodValueUnitDays
At 2013-09-307,917USD
At 2012-12-3111,486USD

Accrued current liabilities

Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.

PeriodValueUnitDays
At 2013-09-30369,066USD
At 2012-12-31230,479USD

Profit or loss including noncontrolling interests

Net income or loss including the portion attributable to noncontrolling interests. It can differ from the net income attributable to the parent that per-share figures use.

PeriodValueUnitDays
2013-04-01 to 2013-09-30-768,788USD183
2004-11-23 to 2013-09-30-8,122,059USD3234
2012-04-01 to 2012-09-30-1,179,410USD183

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

PeriodValueUnitDays
2013-07-01 to 2013-09-30324,457USD92
2013-04-01 to 2013-09-30656,874USD183
2004-11-23 to 2013-09-302,330,118USD3234
2012-07-01 to 2012-09-30320,556USD92
2012-04-01 to 2012-09-30420,928USD183

Interest paid, net

Cash interest paid during the period, net of amounts capitalized where the filer reports it that way. It differs from interest expense recognized.

PeriodValueUnitDays
2013-04-01 to 2013-09-300USD183
2012-04-01 to 2012-09-300USD183

Proceeds from issuing common stock

Cash received from issuing common stock during the period. It is gross of costs only where the filer reports it so, and it does not include noncash issuances.

PeriodValueUnitDays
2013-04-01 to 2013-09-30442,000USD183
2004-11-23 to 2013-09-302,875,058USD3234
2012-04-01 to 2012-09-3060,000USD183

Change in accounts payable

The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.

PeriodValueUnitDays
2013-04-01 to 2013-09-30-127,184USD183
2004-11-23 to 2013-09-3062,926USD3234
2012-04-01 to 2012-09-3031,027USD183

Inspect the source

Entity
ProLung, Inc. / CIK 0001541884
Captured
SEC response SHA-256
26fae87b912f65fc5ab9df3ab6d4cc8d691238e302986003cfa05f4773424079

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001541884.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))